Silver linings in midlife for women with HIV and diabetes
Official title: SAGE: Silver Linings and Aging Experiences Among Midlife Women Living with HIV and Diabetes.
Funded at State University of New York at Buffalo · NIH-11470915 · Data updated 2026-11-12
A short, friendly study looks at how women with HIV, diabetes, or both find positive meaning and stay engaged with care during perimenopause and menopause.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $474,198 |
| NIH project number | 1R21AG105061-01 |
| Project ID | NIH-11470915 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women aged 45 and older living with HIV, diabetes, or both, who are perimenopausal or postmenopausal.
✕Less likely to help
Women under 45 or those without menopause-related considerations may not benefit from these insights.
What this research studies
This project explores how older women living with HIV, diabetes, or both experience midlife challenges and how ‘silver linings’—positive shifts in meaning and connection—might help them stay engaged in care. It will recruit about 120 participants across three groups (HIV only, diabetes only, HIV plus diabetes) and gather surveys that measure well-being, stigma, and health behaviors. The team will compare experiences in two cities, Houston and Buffalo, to understand different community factors. The aim is to identify strengths-based pathways that could improve health outcomes and support sustained care engagement during the transition through menopause.
Why it matters
Potential benefit: If successful, the findings could inform programs that boost resilience and healthcare engagement for aging women with HIV and/or diabetes.
How similar studies have gone: Prior work suggests psychosocial strengths can support health behaviors, but this study focuses on a novel strengths-based pathway in this specific population.
Where this research is happening
-
State University of New York at Buffalo
Amherst, United States Active
Researchers
- Principal investigator: Barr, Emily Anne — State University of New York at Buffalo
- Study coordinator: Barr, Emily Anne
Related research
Other NIH-funded projects on the same topics.
-
Multimodal bioelectroceutical approach to bone regeneration in diabetes and aging
A new approach uses electrical signals and tiny drugs inside special scaffolds to help jawbone heal in people with diabetes or aging-related bone problems.
-
RNA m6A changes that age insulin-making beta cells in diabetes
This work explores whether changes in a common RNA chemical mark called m6A cause aging and loss of function in insulin-producing beta cells in adults with type 1 or type 2 diabetes.
-
Exploring how m6A mRNA methylation affects aging in pancreatic beta cells and diabetes
This study is looking at how a specific chemical change in the genetic material of insulin-producing cells in the pancreas affects their aging and function, especially in people with Type 1 and Type 2 diabetes, to find new ways to help these cells work better and survive longer.
-
Understanding how inflammation affects diabetes in older adults
This study is looking at how long-term inflammation and diabetes are related in older adults, especially how aging and nutrition might play a role, and it hopes to find ways to help seniors stay healthier by understanding these connections better.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.